CG
SLS icon

Cutler Group’s SELLAS Life Sciences SLS Stock Holding History

Cutler Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-300
Closed – – 4876
2022
Q4 		$0 Sell
300
-1,200
-80% -$3.37K ﹤0.01% 5351
2022
Q3 		$3K Sell
1,500
-500
-25% -$1.38K ﹤0.01% 4031
2022
Q2 		$4K Hold
2,000
– – ﹤0.01% 3919
2022
Q1 		$13K Buy
+2,000
New +$11.7K ﹤0.01% 3414
2021
Q4 		– Sell
-200
Closed -$1K – 6266
2021
Q3 		$1K Sell
200
-6,700
-97% -$62.2K ﹤0.01% 5423
2021
Q2 		$76K Sell
6,900
-10,400
-60% -$101K 0.01% 2121
2021
Q1 		$147K Buy
+17,300
New +$142K 0.01% 1478
2017
Q2 		– Sell
-1
Closed – – 7225
2017
Q1 		$0 Hold
1
– – ﹤0.01% 7359
2016
Q4 		$1K Buy
+1
New +$5.82K ﹤0.01% 6131

Other funds holding SLS

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EH
Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return